The RODI Team

Who We Are

Management Team and Board Members

Barbara Geladakis
Barbara Geladakis, MD

University of Belgrade- Spec.Biopathology (Helena Hospital) and Agia Olga Hospital, Phd Candidate. Medical Doctor who has run extensive clinical studies and research projects on reproductive immunology.

She specialized in Athens, Greece, at "Kostantopoulio" General Hospital and at "Helena Venizelou" Maternity Hospital at the outpatient RSA (Repeated Spontaneous Abortions) clinic.

She is a member of the European Society for Reproductive Immunology (ESRI) and a member of the Hellenic Society of Immunology.

Barbara Geladakis is an experienced medical doctor and strong healthcare services professional with a history of working in the hospital & health care industry.

During her specialization she was motivated to study the female immune response to fetus and the procedure of embryo implantation and was focused on research in the field of reproductive immunology. She is actively involved in clinical studies and research projects. Her research interest focuses on pregnancy failures. She is a member of the team of Dr Varla-Leftherioti.

Barbara Geladakis' research resulted in important clinical applications. She has been granted a patent for her work focusing in the enhancement of female fertility with addtionals patents pending.

She is fluent in English, Serbian, Italian, German and Greek.

George Deligiannis
Co-Founder and CTO/COO
George Deligiannis

New York Institute of Technology, Embry-Riddle Aeronautical University, Polytechnic University (NYU). BSc/CS (highest honors) with a minor in Business, MSc/CS (highest honors) concentrating in Robotics, Artificial Intelligence, DBMS design and Computer Networks.

George brings over thirty years worth of experience in advanced systems design, both military and commercial. He worked as a US Dept. of Defense subcontractor for Boeing, Lockheed Martin, McDonnell Douglas, SAAB Aeronautics and NASA.

Projects he worked on include the Boeing 747-400 wide body airliner, the SAAB 340 aircraft, the AH-64 Apache helicopter, The F-117 Stealth Fighter and the OV-103 Discovery space shuttle.

He then went on to join The Rugby-Darby Group – at the time the largest, and best, generic pharmaceuticals manufacturer in the United States with 60 locations throughout the country.

After that he worked as chief technology officer for Saatchi and Saatchi at in their Rowland Worldwide crisis management and public relations division in New York. While at RW he completely redesigned their technology infrastructure making it possible for the company to handle accounts such as McDonald’s, Mars, Canon, Martex and GNTO (the Greek National Tourist Organization aka EOT) with ease, confidence and security.

His next project was the design and implementation of the audio-visual lab for a small, specialized, five-time Clio Award winning advertising firm. There, he also designed the extremely successful websites for and where he was also a partner. The design and functionality of the sites were praised as extremely innovative and way ahead of their time.

George has held the positions of CIO, CTO and/or CINO, or equivalent, since he was 25 years old.

Dora Vardis
Co-Founder and CFO
Dora Vardis

Columbia Business School – MBA in Finance and Financial Markets; Eastern Michigan University – MS in International Finance; University of Athens – BA in Economics and Econometrics.

Dora is a financial services veteran, with over 20 years experience with broker dealer, hedge fund, mutual fund compliance, and human capital development. She has deep expertise across equities, foreign exchange, commodities and credit.

Previously Dora served as Chief Operating Officer and Chief Compliance Officer at Manhattan-based hedge fund Metropolitan Capital Advisors. Prior to this she led IDEAGlobal, a global research firm, as Partner and Executive Vice President. Dora feels very strongly about green sources of power and serves as Board member of Ideacarbon and Carbon Ratings Agency.

Recently Dora is also involved as a Managing Member in a Venture Capital Fund that seeds ventures that have real-world impact leveraging blockchain and distributed ledge technologies; her fund also invests in pre-ICO and early stage equity rounds that are attacking large addressable markets.

Maria Goutsou
Member of the Board
Maria Goutsou

Harvard University T.H. Chan School of Public Health, MS (won the Gerondelis Foundation Award); MIT Sloan School of Management, MBA; Tufts University, MA in Public Policy; National Technical University of Athens, BS in Civil Engineering.

Maria Goutsou is an accomplished executive with 20+ years of experience in building and leading pharmaceutical brands into multi-million-dollar businesses, leading and building commercialization systems for pharmaceutical portfolios and unleashing strategic innovation into business.

She acquired foundational career experience in high-tech and biopharma companies, including Analog Devices, Thermo-Electron, Merck, Otsuka, UCB, Roivant.

Dora Vardis
Member of the Board
Silda Wall-Spitzer

Harvard Law School, JD; Meredith College, BA (Summa Cum Laude) and Honorary Doctorate.

Silda Wall Spitzer brings strong financial, legal, governance, strategic business planning, entrepreneurial and other experience from a professional career spanning the private, public, and nonprofit sectors.

She is Co-founder, CEO and Publisher of, the first digital magazine and marketplace for New York State, and also serves on the Advisory Committee of a green chemistry venture fund and as Senior Advisor to a venture firm building and investing in emerging technology and digital asset companies.

Previously, Ms. Wall Spitzer was Director and Principal at NewWorld Capital Group, a private equity firm investing in environmental opportunities, and Managing Director at the financial firm Metropolitan Capital Advisors. She also practiced corporate law for ten years, first at Skadden and then at Chase Manhattan Bank, where her work included high profile mergers and acquisitions, corporate restructurings and divestitures, corporate finance, and international transactions. As First Lady of New York State, Ms. Wall Spitzer originated and implemented show-the-way economic sustainability, green building, women’s empowerment and other initiatives.

Ms. Wall Spitzer currently serves as Vice Chair of Urban Green Council and member of the Meredith College Board, the Ceres President's Council, and the Advisory Boards of The Sustainable Endowments Institute and the Center for Law, Brain and Behavior. She is also member of the Council on Foreign Relations, the Economic Club of New York, the Women’s Forum of New York, and the New York State and City Bar Associations.

Senator Leonidas P. Raptakis
Member of the Board
Senator Leonidas P. Raptakis

Rhode Island College, BA; Community College of Rhode Island, AA

Senator Raptakisis is a Greek-American politician and a Democratic member of the Rhode Island Senate representing since January 2013.

Raptakis served non-consecutively from January 1997 until January 2011 having served consecutively in the Rhode Island General Assembly from January 1993 until January 1997 in the Rhode Island House of Representatives. He was a candidate for Secretary of State of Rhode Island in 2010.

He is the Vice Chair, Special Legislation and Veterans' Affairs, Member of the Judiciary, of Alpha Omega, of the American Hellenic Educational Progressive Association, of the Annunciation Greek Orthodox Church and several other.

Thanos Niforos
Member of the Board
Thanos Niforos

Hull University, Hull, UK, MBA in Financial Management, European University, Montreux, Switzerland, Bachelor of Business Administration, The George Washington University, WDC, Moody’s Analytics, Emerging Markets Credit Fundamentals, International Faculty of Finance, London School of Private Equity, Bank of Greece, Registered Investment Adviser.

Thanos brings over thirty years’ worth of experience with senior leadership, policymakers and opinion elites in promoting sustainable business solutions for B-to-G and B-to-B investor relations programs, funding rounds and deal sourcing for IPO’s, reverse mergers and SPAC deals, M&As and NPLs with expertise in investment valuations and due diligence for PEVC deals, limited recourse project financing, wealth management and corporate finance structures.

Thanos started his career as an Investment Banking Associate for the National Investment Bank for Industrial Development in Greece, he worked as an investment, corporate officer and IPO analyst in Marfin Bank, as a private wealth manager for UHNWI’s in NBG Private Banking Athens and in SGBT Private Bank Luxemburg and as an investment director for developers, contractors, sponsors and technology providers for alternative energy, esco, cosmetics, medical, hospitality and AI projects in Greece, Cyprus, Chile and UK.

Thanos has served as Loan and Political Risk Originator for the Enterprise Development Network program of Overseas Private Investment Corporation (OPIC) in Washington D.C. as Judge for the African Diaspora Marketplace Business Plan Competition III, SEAF in WDC, as a Business Service Provider for US in the U.S. Commercial Service Office of the US Embassy in Greece and as a Signatory of the United Nations Principles of Responsible Investments. More recently, Thanos has been consulting the European Public Law Organization as a Director of Fund-Raising Affairs and the Greek administration for coordinating, monitoring and controlling the implementation of government policy on the promotion, acceleration and realization of investments in Greece. He worked on economic diplomacy issues promoting direct and indirect foreign investments and implemented an investment relation program for the Greek Ministries and foreign institutional and strategic investors. He was invited by the US Government to represent the Hellenic Republic in Select US 2016.

He is member of The American Hellenic Educational Progressive Association (AHEPA), Delphi Chapter No.25, Manhattan, NYC, Member of the Advisory Committee of the Greek Innovation Strategy Forum and Founder of the Acacia Investor Relations.

Erik Stangvik
Member of the Board
Erik Stangvik

25 years of experience leading private businesses, raising capital and securing funding for new projects,and providing media strategy; owned The Body Shop franchises in Northern California and worked with Anita Roddick for 10 years developing sustainable economic projects around the world.


Chief Scientist

Yula Varla
Founding Member and Chief Scientific Advisor
Marighoula (Youla) Varla-Leftherioti, MD, PhD

Medical Biopathologist, PhD (“National and Kapodistrian” University of Athens, Greece). Involved in Immunology since 1979. Main scientific interests: Transplantation Immunology, Histocompatibility, Reproductive Immunology, Unrelated Donor HSCT.

Remarkable activity for the development of the Hellenic Tranplantation Programme: Head of Hellenic Transplant Service (1989-1991), establishment and responsible person of Athens Bone Marrow Donor Registry (1988-2002), member of the Hellenic Transplant Organization (2004-2010).

Pioneer to introduce Reproductive Immunology in Greece (1986) by starting immunological investigation of RSA couples and publishing a related monograph (Lymphocyte Immunization in Recurrent Spontaneous Abortions, 1992). At her position as the Director of the Immunbiology Department of “Helena Venizelou” Maternity Hospital (1995-2018), she developed it to be unique in Greece for the investigation of couples with immune-mediated sub-fertility problems and organized an out-patient RSA clinic where more than 3.000 couples have been followed. She is actively involved in clinical studies and research projects on original ideas, mainly those with clinical interest and possible application in the clinical setting. Her research interests focus mainly on NK cells and their receptors’ repertoire in RSA couples (KIR/HLA-C allorecognition system in pregnancy), the synergy of infectious and immunological factors in RSA and RIF, and the effect of immunotrophic nutrition in sub-fertile women with NK disturbances. She was the leader of the Reproductive Immunology component at 3 International Histocompatibility Workshops and partner to the “EMBIC-EMRYO IMPLANTATION CONTROL” Network of Excellence, European programme (2005-2008).

Her scientific activities in Greece and Internationally include papers published in journals, chapters published in books, participation to research programmes, lectures as invited speaker to scientific meetings, reviewing of research programmes / papers / abstracts and participation on the Editorial Board of journals.

Apart from her scientific work, she is an active member of Hellenic and International Scientific Societies (three times President of the Hellenic Society of Immunology, President of the Balkan Association of Immunological Societies), she is or has been member of various Committees of Scientific Societies and she is recognized as a very good congress organizer (European Federation of Immunological Societies -EFIS Congress 2003, European Federation of Histocompatibility and Immunogenetics-EFI Congress 2016).

Since 1997, she is an active member of the International Society of Reproductive Immunology-ISIR and the European Societies ESRADI (European Society of Reproductive and Developmental Immunology) and ESRΙ (European Society for Reproductive Immunology) with Executive Boards’participations: ESRADI: Treasurer 2003-2007, ESRI: G. Secretary 2007-2010, President Elect 2010-2013, President 2013-2016, Past President 2016-2019), member (2019-today). The International Coordination Committee for Immunology of Reproduction has awarded her with the “Kiril Bratanov” medal for her contribution to the development of the Committee and to the advancement of Reproductive Immunology, and she was entrusted to organize two ESRI congresses (2003, 2009) and three ESRI Summer Schools (2013, 2017, 2019).